Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 16:10:1645-1653.
doi: 10.2147/OTT.S130910. eCollection 2017.

Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas

Sachin Jain  1 , Ruolan Song  2 , Jingwu Xie  2
Affiliations
Review

Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas

Sachin Jain et al. Onco Targets Ther. .

Abstract

The Hedgehog (Hh) pathway is critical for cell differentiation, tissue polarity, and stem cell maintenance during embryonic development, but is silent in adult tissues under normal conditions. However, aberrant Hh signaling activation has been implicated in the development and promotion of certain types of cancer, including basal cell carcinoma (BCC), medulloblastoma, and gastrointestinal cancers. In 2015, the US Food and Drug Administration (FDA) approved sonidegib, a smoothened (SMO) antagonist, for treatment of advanced BCC (aBCC) after a successful Phase II clinical trial. Sonidegib, also named Odomzo, is the second Hh signaling inhibitor approved by the FDA to treat BCCs following approval of the first SMO antagonist vismodegib in 2012. What are the major features of sonidegib (mechanism of action; metabolic profiles, clinical efficacy, safety, and tolerability profiles)? Will the sonidegib experience help other clinical trials using Hh signaling inhibitors in the future? In this review, we will summarize current understanding of BCCs and Hh signaling. We will focus on sonidegib and its use in the clinic, and we will discuss ways to improve its clinical application in cancer therapeutics.

Keywords: Hedgehog; basal cell carcinoma; cancer; inhibitor; smoothened; sonidegib.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Canonical Hh signaling and noncanonical Hh signaling. Abbreviations: Hh, Hedgehog; PTCH, patched; Shh, Sonic hedgehog; SMO, smoothened.
Figure 2
Figure 2
Generation of Sonidegib. Notes: (A) The structure of compound #1 from a cell-based screening. (B) The structure of sonidegib, which has high biological potency.
Figure 3
Figure 3
Sonidegib interacts with the drug-binding pocket of SMO, which mainly consists of three amino acids: arginine (R) 473, arginine (R) 400, and glutamic acid (E) 518. Abbreviation: SMO, smoothened.
See this image and copyright information in PMC

References

    1. Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in drosophila. Nature. 1980;287(5785):795–801. - PubMed
    1. Krauss S, Concordet JP, Ingham PW. A functionally conserved homolog of the drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryos. Cell. 1993;75(7):1431–1444. - PubMed
    1. Echelard Y, Epstein DJ, St-Jacques B, et al. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell. 1993;75(7):1417–1430. - PubMed
    1. Riddle RD, Johnson RL, Laufer E, Tabin C. Sonic hedgehog mediates the polarizing activity of the ZPA. Cell. 1993;75(7):1401–1416. - PubMed
    1. Chang DT, Lopez A, von Kessler DP, et al. Products, genetic linkage and limb patterning activity of a murine hedgehog gene. Development. 1994;120(11):3339–3353. - PubMed